ZUSTELVI
LIVE

Serial Number

79314245

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

May 11, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ZUSTELVI Trademark

Serial Number: 79314245 • Registration: 7064213

ZUSTELVI is a trademark filed by NOVARTIS AG on May 11, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,174 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

May 11, 2021

Registration Date

May 30, 2023

Published for Opposition

March 14, 2023

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 30, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
May 30, 2023 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 1, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 12, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 12, 2023 OPNR
NOTIFICATION PROCESSED BY IB
Mar 21, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 14, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 14, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 22, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 22, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 22, 2023 NONP
ATTORNEY REVIEW COMPLETED
Feb 9, 2023 ATRV
FINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE
Feb 6, 2023 FINA
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Feb 6, 2023 CREV
REG. CANCELLED - RESTORED TO PENDENCY
May 13, 2022 CRTP
ASSIGNED TO PETITION STAFF
May 11, 2022 APET
REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED
May 6, 2022 RCII
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Feb 10, 2022 GPAR
TEAS SECTION 7 REQUEST RECEIVED
Jan 31, 2022 ES7R
REGISTERED-PRINCIPAL REGISTER
Jan 11, 2022 R.PR
CORRECTION TRANSACTION RECEIVED FROM IB
Nov 14, 2021 CRCV
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 26, 2021 NPUB
PUBLISHED FOR OPPOSITION
Oct 26, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 6, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 16, 2021 CNSA
ASSIGNED TO EXAMINER
Sep 9, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 13, 2021 MAFR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 9, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 9, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 9, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 9, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 9, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 9, 2021 COAR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 7, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 6, 2021 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jun 25, 2021 SDRC